3. New Drug Development Group (AWO)

Publisher： Karger

E-ISSN： 2296-5262|21|3|63-64

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.3, 1998-07, pp. : 63-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Osteoporosis: Pathophysiology and new drug development

By Vondracek Sheryl   Chen Judy   Csako Gyorgy  

Clinical Review in Bone and Mineral Metabolism, Vol. 2, Iss. 4, 2004-12 ,pp. : 293-313

Humana Press, Inc

Access to resources Recommend Favorite

Accelerating Drug Development Through Collaboration: The Hepatitis C Drug Development Advisory Group

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 2, 2014-08 ,pp. : 162-165

John Wiley & Sons Inc

Access to resources Recommend Favorite

A totally new system is needed for drug research and development

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 48, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

pH‐Dependent Drug–Drug Interactions for Weak Base Drugs: Potential Implications for New Drug Development

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 2, 2014-08 ,pp. : 266-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug-Induced Phototoxicity; An Early In Vitro Identification of Phototoxic Potential of New Drug Entities in Drug Discovery and Development

By  

Current Drug Safety, Vol. 4, Iss. 2, 2009-05 ,pp. : 123-136

Bentham Science Publishers

Access to resources Recommend Favorite